Your cart is empty

Mitochondria-Targeted Peptide Research Compound
SS-31 is a mitochondria-targeted peptide studied in laboratory settings for its interaction with cellular energy systems and oxidative stress pathways. Research often focuses on its effects on mitochondrial efficiency, membrane stability, and overall cellular resilience in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
SS-31 is a synthetic tetrapeptide designed for controlled laboratory research involving mitochondrial-associated signaling systems. It is also known in scientific literature as elamipretide.
In research settings, SS-31 is studied in experimental models examining mitochondrial membrane interaction, bioenergetic signaling pathways, and oxidative stress–related regulatory frameworks under in vitro and preclinical conditions.
Third-party tested for purity, identity, quantity.
SS-31 is a mitochondria-targeted peptide evaluated in research focused on membrane-associated signaling and cellular bioenergetics. Experimental studies examine its interaction with mitochondrial membrane components and downstream signaling mechanisms within controlled laboratory environments.
Preclinical research publications have explored its role in mitochondrial function models and oxidative regulatory frameworks under structured experimental conditions.
SS-31 was developed during research efforts aimed at creating small peptides capable of selectively interacting with mitochondrial membranes. Investigations into mitochondrial-targeted peptide design led to the synthesis of compounds evaluated in bioenergetic and oxidative stress–related models.
Subsequent research documented its membrane interaction characteristics and signaling properties within experimental systems.
Laboratory investigations into SS-31 have focused on mitochondrial membrane interaction models and cellular bioenergetic signaling pathways. Research frameworks evaluate peptide interaction with cardiolipin-associated systems, oxidative stress regulation, and mitochondrial functional dynamics under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 50mg of lyophilized SS-31. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Contemporary insights into elamipretide’s mitochondrial mechanism of action and therapeutic effects.
PubMedElamipretide enhances post-thaw rooster sperm quality by mitigating oxidative stress and optimizing mitochondrial function during cryopreservation.
PubMedAcute mitochondrial reactive oxygen species emissions drive mitochondrial dysfunction after traumatic muscle injury in male mice.
PubMedSS-31: A promising therapeutic agent against bleomycin-induced pulmonary fibrosis in mice.
PubMedRelated

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00